Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 14;24(22):2327-2347.
doi: 10.3748/wjg.v24.i22.2327.

Microbial markers in colorectal cancer detection and/or prognosis

Romain Villéger  1 , Amélie Lopès  1 , Julie Veziant  1 , Johan Gagnière  1 , Nicolas Barnich  1 , Elisabeth Billard  1 , Delphine Boucher  1 , Mathilde Bonnet  1
Affiliations
Review

Microbial markers in colorectal cancer detection and/or prognosis

Romain Villéger et al. World J Gastroenterol. .

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer worldwide. CRC is still associated with a poor prognosis among patients with advanced disease. On the contrary, due to its slow progression from detectable precancerous lesions, the prognosis for patients with early stages of CRC is encouraging. While most robust methods are invasive and costly, actual patient-friendly screening methods for CRC suffer of lack of sensitivity and specificity. Therefore, the development of sensitive, non-invasive and cost-effective methods for CRC detection and prognosis are necessary for increasing the chances of a cure. Beyond its beneficial functions for the host, increasing evidence suggests that the intestinal microbiota is a key factor associated with carcinogenesis. Many clinical studies have reported a disruption in the gut microbiota balance and an alteration in the faecal metabolome of CRC patients, suggesting the potential use of a microbial-based test as a non-invasive diagnostic and/or prognostic tool for CRC screening. This review aims to discuss the microbial signatures associated with CRC known to date, including dysbiosis and faecal metabolome alterations, and the potential use of microbial variation markers for non-invasive early diagnosis and/or prognostic assessment of CRC and advanced adenomas. We will finally discuss the possible use of these markers as predicators for treatment response and their limitations.

Keywords: Colibactin-producing E. coli; Colorectal cancer; Diagnostic markers; Dysbiosis; F. nucleatum; Microbiota; Prognostic markers.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: None of the authors have any conflicts of interest to declare.

Figures

Figure 1
Figure 1
Bacterial and metabolic composition shifts during carcinogenesis. BFT: B. fragilis toxin.
Figure 2
Figure 2
Metabolism of food dietary components by the gut microbiota. Dietary residues are in blue, intermediate metabolites in green, SCFAs in red, and other metabolites in grey. Adapted from Louis et al[255], Russel et al[184] ; Rowland et al[172] ; Flint et al[171]. SCFAs: Short chain fatty acids.
See this image and copyright information in PMC

References

    1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117. - PubMed
    1. Rees CJ, Bevan R. The National Health Service Bowel Cancer Screening Program: the early years. Expert Rev Gastroenterol Hepatol. 2013;7:421–437. - PubMed
    1. Jones RP, Jackson R, Dunne DF, Malik HZ, Fenwick SW, Poston GJ, Ghaneh P. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg. 2012;99:477–486. - PubMed
    1. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–1425. - PubMed
    1. Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60:596–608. - PubMed